DECREASING ALBUMIN mRNA EXPRESSION IN CHOLANGIOCARCINOMAS ALONG THE BILE DUCT TREE.

The progressive technologies in Albumin in situ hybridization (ISH) changed the routine application and the differential diagnosis of hepatic malignancies in the last years. The aim of the present work was to assess the diagnostic utility of albumin ISH on different cholangiocarcinoma (CCA) subtypes, as well as to assess how albumin production changes along the biliary tree. Forty-five CCAs were retrospectively selected: 29 intrahepatic (15 small-duct and 14 large-duct subtypes), 7 peri-hilar and 9 extrahepatic. Histology was revised in all cases, and Albumin ISH was automatically performed by the RNAscope®. ISH was always negative in extrahepatic CCAs, only 1 peri-hilar case was positive, and any positivity was observed in 25/29 (86.2%) intrahepatic CCAs (p<0.001). Concerning CCA subtypes, mean cell positivity was 38.8±29.8% in small-duct CCAs and 11.4±21.9 in large-duct CCAs respectively (p=0.003); 12/15 (80.0%) small-duct and 3/14 (21.4%) large-duct CCAs showed >5% positive cells (p=0.002; odd-ratio 14.7). The introduction of more sensitive techniques changed the indications for ISH, since most small-duct intrahepatic CCAs show diffuse positivity. Albumin positivity decreases from liver periphery to the large ducts, suggesting that ISH can be helpful in the differential diagnosis between small-duct and large-duct CCAs, as well as between intrahepatic large-duct CCAs and metastases.

Informations de copyright

The Author(s). Published by S. Karger AG, Basel.